1 March 2016 in Sleep Medicine
26 April 2012 in The Cerebellum
7 February 2013 in Acta Ophthalmologica
: Purpose: To identify the underlying molecular genetic cause in a Czech family with optic atrophy, deafness, ptosis, ophthalmoplegia, polyneuropathy and ataxia transmitted as an autosomal dominant trait.Methods: Ophthalmological and neurological examination followed by molecular genetic analyses.Results: Seven family members were clinically affected. There was a variable but progressive visual, hearing and neurological disability across the family as a whole. The majority of subjects presented with impairment of visual function and a variable degree of ptosis and/or ophthalmoplegia from the first to the third decade of life. Deafness, neuropathy and ataxia appeared later, in the third and fourth decade. Migraine, tachycardia, intention tremor, nystagmus and cervical dystonia were observed in isolated individuals. A significant overall feature was the high level of neurological disability leading to 3 of 4 members being unable to walk or stand unaided before the age of 60 years. A novel missense mutation c.1345A>C (p.Thr449Pro) in OPA1 segregating with the disease phenotype over three generations was detected. In silico analysis supported pathogenicity of the identified sequence variant.Conclusion: Our work expands the spectrum of mutation in OPA1, which may lead to severe multisystem neurological disorder. The molecular genetic cause of dominant optic atrophy in the Czech population is reported for the first time. We propose that regular cardiac follow‐up in patients diagnosed with dominant optic atrophy and widespread neurological disease should be considered.
1 May 2011 in Journal of Neuroscience Methods
5 May 2021 in Movement Disorders
Background: Despite the established value of genomic testing strategies, practice guidelines for their use do not exist in many indications.Objectives: We sought to validate a recently introduced scoring algorithm for dystonia, predicting the diagnostic utility of whole‐exome sequencing (WES) based on individual phenotypic aspects (age‐at‐onset, body distribution, presenting comorbidity).Methods: We prospectively enrolled a set of 209 dystonia‐affected families and obtained summary scores (0–5 points) according to the algorithm. Singleton (N = 146), duo (N = 11), and trio (N = 52) WES data were generated to identify genetic diagnoses.Results: Diagnostic yield was highest (51%) among individuals with a summary score of 5, corresponding to a manifestation of early‐onset segmental or generalized dystonia with coexisting non‐movement disorder‐related neurological symptoms. Sensitivity and specificity at the previously suggested threshold for implementation of WES (3 points) was 96% and 52%, with area under the curve of 0.81.Conclusions: The algorithm is a useful predictive tool and could be integrated into dystonia routine diagnostic protocols. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society
19 December 2017 in Journal of Neural Transmission